CTRI/2011/12/002300招募中4 期
A PROSPECTIVE, DOUBLE-BLIND RANDOMISED CONTROL TRIAL TO COMPARE EFFICACY AND SAFETY OF 25 mcg vs. 50 mcg MISOPROSTOL FOR INDUCTION OF LABOUR
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a.Age 18-35 completed years, with obstetric or medical indications for induction of labour.
- •b.37 to 42 weeks of gestation.
- •c.Singleton fetus.
- •d.Cephalicpresentation.
- •e.Bishop score less than 6.
- •f.Parity less than 2.
- •g.Four or fewer contraction per hour.
- •h.Reactive non-stress test (NST).
排除标准
- •Presence of any below mentioned criteria will exclude the participant from the study.
- •a.Abnormal fetal heart pattern.
- •b.Contraindication to vaginal delivery: Malpresentation, suspected cephalopelvic disproportion, placenta previa, abruption placentae.
- •c.Previous cesarean delivery or uterine surgery.
- •d.Unexplained vaginal bleeding.
- •e.Any contraindication to receiving prostaglandins (e.g. asthma, h/o cardiac disease, glaucoma).
- •f.Previous attempt of labor induction for the present pregnancy.
- •g.Active herpes simplex virus infection.
- •h.Parity greater than 2.
- •i.Nonsteroidalanti-inflammatory drugs (including aspirin) within 4 hours of the study drug treatment.
- •j.Pyrexia100?aF.
- •k.Prior serious adverse event related to prostaglandin administered by any route for any indication.
研究者
相似试验
尚未招募
不适用
A STUDY FOR COMPARING THE EFFECT OF MIFEPRISTONE WITH MISOPROSTOL FOR INDUCTION OF LABORCTRI/2013/11/004151Govt of HP100
已完成
4 期
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF EARLY TREATMENT WITH EPLERENONE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIOHeart attack10028593NL-OMON36477Pfizer10
进行中（未招募）
不适用
Clinical trial exploring treatment benefits and safety of early administration of eplerenone in patients with heart attacks compared with placebo.ACUTE MYOCARDIAL INFARCTIONMedDRA version: 14.1Level: PTClassification code 10000891Term: Acute myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-019844-38-GBPfizer Inc., 235 East 42nd Street, New York, NY 100171,012
已完成
3 期
A PROBIOTIC PREPARATION, VSL#3, FOR THE TREATMENT OF MILD TO MODERATELY ACTIVE ULCERATIVE COLITISCTRI/2008/091/000076CD Pharma India Pvt Ltd150
进行中（未招募）
1 期
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF EARLY TREATMENT WITH EPLERENONE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION - Not ApplicableACUTE MYOCARDIAL INFARCTIONEUCTR2010-019844-38-SKPfizer Inc.612